Is Emerson Electric Stock Outperforming the Nasdaq?

Is Emerson Electric Stock Outperforming the Nasdaq?

Sristi Jayaswal

Mon, September 7, 2026 at 3:40 PM GMT+3 4 min read

• EMR -0.44%
• ^IXIC -0.32%

When we think about the machinery and technology that keep factories running, Emerson Electric Co. (EMR) is one of those names working behind the scenes. The Saint Louis, Missouri-based technology and software company has been around since 1890 and today serves customers across the Americas, Europe, Asia, the Middle East, and Africa. Its business spans everything from automation and control systems to measurement tools, industrial software, valves, and safety solutions.

Through brands such as Fisher, Rosemount, DeltaV, and RIDGID, Emerson helps industries measure, monitor, automate, and manage their operations. Whether it is controlling a plant process or improving workplace safety, the company's products are deeply woven into modern industrial operations.

More News from Barchart

That scale is also reflected in Emerson's market value. With a market capitalization of approximately $85.6 billion, the company comfortably falls within the "large-cap" category, which generally includes companies valued at $10 billion or more. Its sizeable market cap highlights Emerson's established presence, broad industrial footprint, and strong position within the specialty industrial machinery industry.

That solid performance has kept EMR on investors' radar, although the stock has pulled back a bit from its recent peak. Shares are currently 8.1% below the 52-week high of $166.35 reached on Aug. 12. Still, the broader picture remains encouraging. Over the past three months, EMR has gained 7.6%, easily beating the Nasdaq Composite's ($NASX) 1.2% slip during the same period.

So far in 2026, the stock is up 15.1%, slightly ahead of the index's 14.1% gain. However, over the past 52 weeks, EMR's 14.8% advance has trailed the Nasdaq's stronger 22.1% return, showing that its recent momentum has been more convincing than its longer-term performance.

The stock may have had a few wobbles, but the technical picture still looks encouraging. EMR has stayed above both its 50-day and 200-day moving averages since July, suggesting that buyers continue to have the upper hand. For now, that positioning points to a healthy underlying trend and keeps the stock's longer-term momentum looking positive.

EMR's gains in 2026 have been backed by a combination of stronger financial results, improving profitability, and Emerson's continued shift toward higher-margin businesses. For instance, the company's Q3 2026 results gave investors a reason to cheer, with revenue rising 7% year over year (YOY) and adjusted EPS climbing 13%, helped by stronger organic sales and operational improvements. The market responded quickly, with shares gaining more than 2% following the report.

There is also a noticeable improvement in profitability. Emerson's free cash flow margin reached 27.1%, while its Software & Systems segment stood out with 11% revenue growth and a 20% increase in earnings. That shift toward industrial automation and digital software has strengthened the company's growth profile. Management has also raised its 2026 adjusted EPS guidance to the upper end of its previous range and expects to return about $2.2 billion to shareholders this year. Adding in 68 consecutive years of dividend increases and a 1.45% forward yield, investors have plenty to like EMR stock.

When stacked against its closest peer in the industrial space, Eaton Corporation plc (ETN) has climbed 18% over the past year and 29% in 2026, outperforming EMR stock.

The analyst view on EMR remains encouraging, though not overwhelmingly bullish. Of the 26 analysts covering the stock, the consensus rating stands at "Moderate Buy." Meanwhile, the average price target of $171.69 implies about 12.3% upside from current levels, suggesting Wall Street sees further room for the stock to appreciate.

On the date of publication, Sristi Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com